CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price fell 1.8% during mid-day trading on Wednesday after an insider sold shares in the company. The company traded as low as $56.75 and last traded at $56.90. 296,744 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 1,831,639 […]
Related Keywords
Blackrock , Nova Scotia , Canada , Samarth Kulkarni , Raju Prasad , T Rowe Price Investment Management Inc , Capital International Investors , Royal Bank , Investment Management , Blackrock Inc , Pricet Rowe Associates Inc , Wells Fargo Company , Get Free Report , Chardan Capital , International Investors , Rowe Price Investment Management , Crispr Therapeutics , Nasdaq Crsp , Crsp , Medical , Stocks , Technicals ,
vimarsana.com © 2020. All Rights Reserved.